Skip to main content
. 2014 Mar;11(1):64–68. doi: 10.7497/j.issn.2095-3941.2014.01.006

Figure 4.

Figure 4

Modification of LC3 and Bcelin1 in HepG2 cells after treatment with IFN-α2b. 1, control group; 2, cells treated with 100 IU/mL IFN-α2b; 3, cells treated with 1,000 IU/mL IFN-α2b; 4, cells treated with 10,000 IU/mL IFN-α2b.